{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T06:30:53Z","timestamp":1785047453019,"version":"3.55.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>The treatment of inflammatory bowel disease (IBD) is still challenging. Therefore, it is crucial not only to develop new drugs specifically targeting IBD but also to evaluate the application and efficacy of already established pharmaceuticals used for related disorders. A promising new candidate is Voclosporin (Voc), a recently approved drug for lupus nephritis. In this study, we aimed to further elucidate the efficiency and the molecular mechanism of action of Voclosporin in comparison with its analogon cyclosporine A (CsA). Using an experimental colitis model and human PBMCs, we performed a comprehensive analysis including mini-endoscopy, histopathology, multi-photon endomicroscopy (MPEM), immunofluorescence staining, flow cytometry, and cytokine secretion profiling of murine lamina propria mononuclear cells (LPMCs). Treatment with Voc or CsA improved colitis-associated weight loss and reduced intestinal inflammation as assessed by endoscopy and histopathological stainings. Treatment with Voclosporin led to a significant increase of the barrier-strengthening protein claudin 3 in the colon of mice with experimentally induced colitis. Furthermore, treatment of stimulated human-derived PBMCs from healthy controls with Voclosporin and CsA inhibited the activation of IL2-inducible tyrosine kinase ITK, a known trigger of inflammation in IBD. These results further support the potential of Voclosporin as a promising therapeutic strategy for the treatment of acute intestinal inflammation.<\/jats:p>","DOI":"10.3389\/fmed.2026.1750826","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:38:22Z","timestamp":1770035902000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Voclosporin shows protective effect and intestinal barrier enforcement in experimental colitis"],"prefix":"10.3389","volume":"13","author":[{"given":"M.","family":"Gabel","sequence":"first","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Knauss","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mohamed Abdou","sequence":"additional","affiliation":[{"name":"Division of Molecular and Experimental Surgery, Department of Surgery, Translational Research Center, Friedrich-Alexander University Erlangen-N\u00fcrnberg and University Hospital Erlangen","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Loges","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"St\u00fcrzl","sequence":"additional","affiliation":[{"name":"Division of Molecular and Experimental Surgery, Department of Surgery, Translational Research Center, Friedrich-Alexander University Erlangen-N\u00fcrnberg and University Hospital Erlangen","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sch\u00fcrmann","sequence":"additional","affiliation":[{"name":"Institute of Medical Biotechnology, Friedrich-Alexander University Erlangen-N\u00fcrnberg","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Waldner","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"Neurath","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen","place":["Erlangen, Germany"]},{"name":"Deutsches Zentrum Immuntherapie (DZI)","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Weigmann","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University Hospital Erlangen","place":["Erlangen, Germany"]},{"name":"FAU Profile Center Immunomedicine","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"5","author":"Alatab","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy","volume":"330","author":"Lichtiger","year":"1994","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/ecco-jcc\/jjaa226","article-title":"Ciclosporin or infliximab as rescue therapy in acute Glucorticosteroid-refractory ulcerative colitis: systematic review and network Meta-analysis","volume":"15","author":"Barberio","year":"2021","journal-title":"J Crohns Colitis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1136\/gutjnl-2016-313060","article-title":"Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab","volume":"67","author":"Laharie","year":"2018","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.ackd.2019.08.006","article-title":"The many faces of calcineurin inhibitor toxicity\u2014what the FK?","volume":"27","author":"Farouk","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/CPAA.S255789","article-title":"Pharmacokinetic disposition difference between cyclosporine and voclosporin drives their distinct efficacy and safety profiles in clinical studies","volume":"12","author":"Li","year":"2020","journal-title":"Clinical pharmacology: advances and applications"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/art.42657","article-title":"Safety and efficacy of long-term Voclosporin treatment for lupus nephritis in the phase 3 AURORA 2 clinical trial","volume":"76","author":"Saxena","year":"2023","journal-title":"Arthritis & Rheumatology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1177450","DOI":"10.3389\/fmed.2023.1177450","article-title":"Protective effect of the novel calcineurin inhibitor voclosporin in experimental colitis","volume":"10","author":"Lindemann","year":"2023","journal-title":"Front Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00109-020-01958-z","article-title":"Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis","volume":"98","author":"Lechner","year":"2020","journal-title":"J Mol Med (Berl)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1053\/j.gastro.2021.06.072","article-title":"Targeting of the Tec kinase ITK drives resolution of T cell-mediated colitis and emerges as potential therapeutic option in ulcerative colitis","volume":"161","author":"Lechner","year":"2021","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"102842","DOI":"10.1016\/j.isci.2021.102842","article-title":"Targeting ITK signaling for T cell-mediated diseases","volume":"24","author":"Weeks","year":"2021","journal-title":"iScience"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"102286","DOI":"10.1016\/j.isci.2021.102286","article-title":"Targeting SLP76:ITK interaction separates GVHD from GVL in Allo-HSCT","volume":"24","author":"Mammadli","year":"2021","journal-title":"iScience."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"a002287","DOI":"10.1101\/cshperspect.a002287","article-title":"T-cell signaling regulated by the Tec family kinase, Itk","volume":"2","author":"Andreotti","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4049\/jimmunol.179.1.111","article-title":"A key role for Itk in both IFN gamma and IL-4 production by NKT cells","volume":"179","author":"Au-Yeung","year":"2007","journal-title":"J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/1471-2164-10-233","article-title":"Transcriptional signatures of Itk-deficient CD3+, CD4+ and CD8+ T-cells","volume":"10","author":"Blomberg","year":"2009","journal-title":"BMC Genomics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.4049\/jimmunol.1501828","article-title":"A small molecule inhibitor of ITK and RLK impairs Th1 differentiation and prevents colitis disease progression","volume":"195","author":"Cho","year":"2015","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.immuni.2004.07.005","article-title":"Cyclophilin a regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk","volume":"21","author":"Colgan","year":"2004","journal-title":"Immunity"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4049\/jimmunol.1900853","article-title":"Activation of the Tec kinase ITK controls graded IRF4 expression in response to variations in TCR signal strength","volume":"205","author":"Conley","year":"2020","journal-title":"J Immunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/BST20190486","article-title":"Tuning T helper cell differentiation by ITK","volume":"48","author":"Elmore","year":"2020","journal-title":"Biochem Soc Trans"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1053\/j.gastro.2020.05.081","article-title":"Label-free in vivo histopathology of experimental colitis via 3-channel multiphoton endomicroscopy","volume":"159","author":"Krei\u00df","year":"2020","journal-title":"Gastroenterology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.3390\/molecules29194577","article-title":"Biochemical modulators of tight junctions (TJs): Occludin, claudin-2 and zonulin as biomarkers of intestinal barrier leakage in the diagnosis and assessment of inflammatory bowel disease progression","volume":"29","author":"G\u00f3recka","year":"2024","journal-title":"Molecules"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3389\/fimmu.2019.01441","article-title":"Claudin family participates in the pathogenesis of inflammatory bowel diseases and colitis-associated colorectal cancer","volume":"10","author":"Zhu","year":"2019","journal-title":"Front Immunol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2282789","DOI":"10.1080\/19490976.2023.2282789","article-title":"Loss of claudin-3 expression increases colitis risk by promoting gut Dysbiosis","volume":"15","author":"Ahmad","year":"2023","journal-title":"Gut Microbes"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nprot.2017.044","article-title":"Chemically induced mouse models of acute and chronic intestinal inflammation","volume":"12","author":"Wirtz","year":"2017","journal-title":"Nat Protoc"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41577-024-01008-6","article-title":"Strategies for targeting cytokines in inflammatory bowel disease","volume":"24","author":"Neurath","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"103017","DOI":"10.1016\/j.autrev.2021.103017","article-title":"The influence of cytokines on the complex pathology of ulcerative colitis","volume":"21","author":"Nakase","year":"2022","journal-title":"Autoimmun Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00823-w","article-title":"T cell receptor (TCR) signaling in health and disease","volume":"6","author":"Shah","year":"2021","journal-title":"Signal Transduct Tar"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3109\/00365521.2012.741616","article-title":"Expression profiling of claudins in the human gastrointestinal tract in health and during inflammatory bowel disease","volume":"48","author":"Lameris","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1742-4658.2007.06210.x","article-title":"Effect of n-3 polyunsaturated fatty acids on membrane microdomain localization of tight junction proteins in experimental colitis","volume":"275","author":"Li","year":"2008","journal-title":"FEBS J"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e24978","DOI":"10.4161\/tisb.24978","article-title":"Claudins in intestines: distribution and functional significance in health and diseases","volume":"1","author":"Lu","year":"2013","journal-title":"Tissue barriers"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1084\/jem.20011956","article-title":"The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn\u2019s disease","volume":"195","author":"Neurath","year":"2002","journal-title":"J Exp Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.3110","article-title":"Enhanced detection of myeloperoxidase activity in deep tissues through luminescent excitation of near-infrared nanoparticles","volume":"19","author":"Zhang","year":"2013","journal-title":"Nat Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1136\/gut.2004.061283","article-title":"In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy","volume":"54","author":"Becker","year":"2005","journal-title":"Gut"},{"key":"ref35","first-page":"4557","article-title":"A guide to histomorphological evaluation of intestinal inflammation in mouse models","volume":"7","author":"Erben","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/978-1-4939-6786-5_20","article-title":"Monitoring of chemically induced colitis","author":"Rei\u00dfig","year":"2017","journal-title":"Inflammation: Methods and Protocols"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1750826\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:38:25Z","timestamp":1770035905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1750826\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":38,"alternative-id":["10.3389\/fmed.2026.1750826"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1750826","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"article-number":"1750826"}}